Teva Wants Out of Case Targeting Blockbuster MS Drug

By Greg Lamm (March 9, 2023, 8:02 PM EST) -- Teva Pharmaceuticals Ltd. said Thursday it should be able to escape insurance payor claims alleging an elaborate campaign to suppress generic competition for Teva's multiple sclerosis drug Copaxone, arguing the claims are time-barred and the payors can't sue because they are not direct drug purchasers....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!